193 related articles for article (PubMed ID: 12699842)
1. VEGF gene therapy for coronary artery disease and peripheral vascular disease.
Rasmussen HS; Rasmussen CS; Macko J
Cardiovasc Radiat Med; 2002; 3(2):114-7. PubMed ID: 12699842
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic angiogenesis with vascular endothelial growth factor in peripheral and coronary artery disease: a review.
Kusumanto YH; Hospers GA; Mulder NH; Tio RA
Int J Cardiovasc Intervent; 2003; 5(1):27-34. PubMed ID: 12623562
[TBL] [Abstract][Full Text] [Related]
3. Regional Angiogenesis with Vascular Endothelial Growth Factor (VEGF) in peripheral arterial disease: Design of the RAVE trial.
Rajagopalan S; Mohler E; Lederman RJ; Saucedo J; Mendelsohn FO; Olin J; Blebea J; Goldman C; Trachtenberg JD; Pressler M; Rasmussen H; Annex BH; Hirsch AT;
Am Heart J; 2003 Jun; 145(6):1114-8. PubMed ID: 12796772
[TBL] [Abstract][Full Text] [Related]
4. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.
Rajagopalan S; Mohler ER; Lederman RJ; Mendelsohn FO; Saucedo JF; Goldman CK; Blebea J; Macko J; Kessler PD; Rasmussen HS; Annex BH
Circulation; 2003 Oct; 108(16):1933-8. PubMed ID: 14504183
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy with vascular endothelial growth factor reduces angina.
Merkle CJ; Montgomery DW
J Cardiovasc Nurs; 2003; 18(1):38-43. PubMed ID: 12537088
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: safety results from a phase I trial.
Mohler ER; Rajagopalan S; Olin JW; Trachtenberg JD; Rasmussen H; Pak R; Crystal RG
Vasc Med; 2003; 8(1):9-13. PubMed ID: 12866606
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor (VEGF165) and its influence on angiogenesis versus arteriogenesis in different vascular beds.
Nikol S; Pelisek J; Engelmann MG; Shimizu M; Fuchs A; Golda A; Armeanu S; Mekkaoui C; Rolland PH
J Endovasc Ther; 2002 Dec; 9(6):842-54. PubMed ID: 12546587
[TBL] [Abstract][Full Text] [Related]
8. Systemic interleukin-6 responses following administration of adenovirus gene transfer vectors to humans by different routes.
Ben-Gary H; McKinney RL; Rosengart T; Lesser ML; Crystal RG
Mol Ther; 2002 Aug; 6(2):287-97. PubMed ID: 12349828
[TBL] [Abstract][Full Text] [Related]
9. Plasma vascular endothelial growth factor (VEGF) levels after intramuscular and intramyocardial gene transfer of VEGF-1 plasmid DNA.
Freedman SB; Vale P; Kalka C; Kearney M; Pieczek A; Symes J; Losordo D; Isner JM
Hum Gene Ther; 2002 Sep; 13(13):1595-603. PubMed ID: 12228014
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ.
Vajanto I; Rissanen TT; Rutanen J; Hiltunen MO; Tuomisto TT; Arve K; Närvänen O; Manninen H; Räsänen H; Hippeläinen M; Alhava E; Ylä-Herttuala S
J Gene Med; 2002; 4(4):371-80. PubMed ID: 12124979
[TBL] [Abstract][Full Text] [Related]
11. Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121.
Lee LY; Patel SR; Hackett NR; Mack CA; Polce DR; El-Sawy T; Hachamovitch R; Zanzonico P; Sanborn TA; Parikh M; Isom OW; Crystal RG; Rosengart TK
Ann Thorac Surg; 2000 Jan; 69(1):14-23; discussion 23-4. PubMed ID: 10654479
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated gene transfer of VEGF(121) improves lower-extremity endothelial function and flow reserve.
Rajagopalan S; Shah M; Luciano A; Crystal R; Nabel EG
Circulation; 2001 Aug; 104(7):753-5. PubMed ID: 11502697
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.
Rosengart TK; Lee LY; Patel SR; Sanborn TA; Parikh M; Bergman GW; Hachamovitch R; Szulc M; Kligfield PD; Okin PM; Hahn RT; Devereux RB; Post MR; Hackett NR; Foster T; Grasso TM; Lesser ML; Isom OW; Crystal RG
Circulation; 1999 Aug; 100(5):468-74. PubMed ID: 10430759
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic angiogenesis by angiogenic growth factor].
Makino H; Ogihara T; Morishita R
Nihon Rinsho; 2003 Apr; 61 Suppl 4():692-7. PubMed ID: 12735051
[No Abstract] [Full Text] [Related]
15. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA.
Rosengart TK; Lee LY; Patel SR; Kligfield PD; Okin PM; Hackett NR; Isom OW; Crystal RG
Ann Surg; 1999 Oct; 230(4):466-70; discussion 470-2. PubMed ID: 10522716
[TBL] [Abstract][Full Text] [Related]
16. A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial.
Kastrup J; Jørgensen E; Fuchs S; Nikol S; Bøtker HE; Gyöngyösi M; Glogar D; Kornowski R
EuroIntervention; 2011 Feb; 6(7):813-8. PubMed ID: 21252014
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for myocardial angiogenesis: with direct intramuscular gene transfer of naked deoxyribonucleic acid encoding vascular endothelial growth factor and cell transplantation of vascular endothelial growth factor transfected H9c2 myoblast.
Sugimoto T; Inui K; Shimazaki Y
Jpn J Thorac Cardiovasc Surg; 2003 May; 51(5):192-7. PubMed ID: 12776950
[TBL] [Abstract][Full Text] [Related]
18. [Growth factors for therapeutic angiogenesis in cardiovascular diseases].
Vale PR; Losordo DW; Symes JF; Isner JM
Rev Esp Cardiol; 2001 Oct; 54(10):1210-24. PubMed ID: 11591302
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of corneal neovascularization by recombinant adenovirus mediated antisense VEGF RNA.
Lai CM; Spilsbury K; Brankov M; Zaknich T; Rakoczy PE
Exp Eye Res; 2002 Dec; 75(6):625-34. PubMed ID: 12470964
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic angiogenesis: protein-based therapy for coronary artery disease.
Khan TA; Sellke FW; Laham RJ
Expert Opin Pharmacother; 2003 Feb; 4(2):219-26. PubMed ID: 12562312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
